Navigation Links
Caliper Life Sciences Launches Living Image(R) 4.0 Software
Date:12/3/2009

HOPKINTON, Mass., Dec. 3 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP), a leading provider of tools and services for drug discovery and life sciences research, today introduced Living Image 4.0 software for IVIS® in vivo imaging systems. Living Image software drives the more than 800 Caliper IVIS systems currently installed in laboratories worldwide. Living Image 4.0 features advanced spectral unmixing tools to enhance fluorescent sensitivity and automated 3D image acquisition and analysis providing an anatomical view of disease activity and drug efficacy.

Preclinical imaging for translational research is now routinely used in large scale studies for drug discovery and vaccine development. With Living Image 4.0, scientists can easily visualize and track diseases quantitatively, in small living animals through the sensitive detection of fluorescent and bioluminescent reporters and functional markers. 3D images generated with Living Image 4.0 can also be co-registered with CT or MRI results to provide enhanced anatomical context for optical molecular signals.

The software's new design creates an intuitive, seamless workflow for researchers of all skill levels. New features include: wizard based guidance for advanced imaging protocols, improved surface tomography, advanced spectral unmixing tools, new color templates and 3D visualization tools. All IVIS systems are calibrated to NIST standards to ensure that quantitative results are validated throughout an experiment and from location to location.

"Caliper's IVIS systems are widely recognized as the leading small animal molecular imaging instrument for drug discovery and development," said Kevin Hrusovsky, president and chief executive officer, Caliper Life Sciences. "Living Image 4.0 will further enhance IVIS's value to scientists by improving its ease-of-use, quantitation and reproducibility."

Living Image 4.0 began shipping with all new IVIS in vivo imaging systems on November 30, 2009. Upgrades to Living Image 4.0 for existing IVIS systems will be available for purchase January 1, 2010.

For additional information on Caliper's portfolio of optical imaging systems, please visit http://www.caliperls.com/products/optical-imaging/.

About Caliper Life Sciences

Caliper Life Sciences is a premier provider of cutting-edge technologies enabling researchers in the life sciences industry to create life-saving and enhancing medicines and diagnostic tests more quickly and efficiently. Caliper is aggressively innovating new technology to bridge the gap between in vitro assays and in vivo results, enabling the translation of those results into cures for human disease. Caliper's portfolio of offerings includes state-of-the-art microfluidics, lab automation & liquid handling, optical imaging technologies, and discovery & development outsourcing solutions. For more information please visit www.caliperLS.com.

Caliper, Living Image and IVIS are registered trademarks of Caliper Life Sciences, Inc.

SOURCE Caliper Life Sciences, Inc.


'/>"/>
SOURCE Caliper Life Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Caliper Life Sciences Expands Suite of Reagents Supporting the IVIS Family of In Vivo Imaging Systems
2. Caliper Life Sciences Launches IVIS(R) In Vivo Imaging System with X-Ray
3. Caliper Life Sciences Reports Second Quarter 2009 Results
4. Caliper Life Sciences Second Quarter 2009 Financial Results Conference Call Notice
5. Caliper Life Sciences Introduces Staccato Protein Workstation for Automated Protein Sample Preparation & Analysis
6. Caliper Life Sciences to Webcast Investor Session of Open House
7. Caliper Life Sciences Reports First Quarter 2009 Results
8. Caliper Life Sciences Announces Date and Location of its 2009 Annual Meeting of Stockholders
9. EPA Presents Initial Results from Caliper Life Sciences ToxCast Screening Effort
10. Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results
11. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... SILVER SPRING, Md. , June 23, 2016 ... evidence collected from the crime scene to track the criminal ... sick, and the U.S. Food and Drug Administration (FDA) uses ... Sound far-fetched? It,s not. ... whole genome sequencing to support investigations of foodborne illnesses. Put ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
Breaking Biology Technology:
(Date:5/20/2016)... , May 20, 2016  VoiceIt is excited ... with VoicePass. By working together, VoiceIt ...  Because VoiceIt and VoicePass take slightly different approaches ... increases both security and usability. ... about this new partnership. "This marketing ...
(Date:5/9/2016)... DUBAI , UAE, May 9, 2016 ... choice when it comes to expanding freedom for high ... Even in today,s globally connected world, there ... online conferencing system could ever duplicate sealing your deal ... are obtaining second passports by taking advantage of citizenship ...
(Date:4/28/2016)... 2016 First quarter 2016:   ... with the first quarter of 2015 The gross margin ... (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... unchanged, SEK 7,000-8,500 M. The operating margin for 2016 ...
Breaking Biology News(10 mins):